AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 175 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $800,000 | -17.9% | 40,000 | -20.0% | 0.28% | +63.8% |
| Q2 2018 | $975,000 | -3.3% | 50,000 | 0.0% | 0.17% | +5.5% |
| Q1 2018 | $1,008,000 | -42.6% | 50,000 | -62.3% | 0.16% | -50.3% |
| Q4 2017 | $1,756,000 | +90.2% | 132,500 | +165.0% | 0.33% | +101.2% |
| Q3 2017 | $923,000 | -18.6% | 50,000 | +88.0% | 0.16% | -78.5% |
| Q4 2014 | $1,134,000 | – | 26,596 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 740,585 | $17,330,000 | 8.11% |
| Palo Alto Investors LP | 2,906,194 | $68,005,000 | 5.28% |
| Opaleye Management Inc. | 220,000 | $5,148,000 | 3.21% |
| Endurant Capital Management LP | 265,180 | $6,205,000 | 2.01% |
| FALCON POINT CAPITAL, LLC | 381,081 | $8,917,000 | 1.54% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 1,470,000 | $34,398,000 | 1.06% |
| AlphaOne Investment Services, LLC | 91,824 | $2,149,000 | 0.88% |
| ASHFORD CAPITAL MANAGEMENT INC | 153,325 | $3,588,000 | 0.85% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 55,097 | $1,289,000 | 0.84% |
| Camber Capital Management LP | 600,000 | $14,040,000 | 0.82% |